These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1541831)

  • 21. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T; Irie RF; Nishinaka Y; Hoon DS
    Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel HLA-B35 subtypes: putative gene conversion events with donor sequences from alleles common in native Americans (HLA-B*4002 or B*4801).
    Marcos CY; Fernández-Vina MA; Lázaro AM; Nulf CJ; Raimondi EH; Stastny P
    Hum Immunol; 1997 Apr; 53(2):148-55. PubMed ID: 9129972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
    Bioley G; Guillaume P; Luescher I; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Valmori D; Ayyoub M
    Clin Cancer Res; 2009 Jan; 15(1):299-306. PubMed ID: 19118058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.
    Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY
    J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
    Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
    J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
    Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
    J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells.
    Nakayama S; Kawaguchi G; Karaki S; Nagao T; Uchida H; Kashiwase K; Akaza T; Nasuno T; Takiguchi M
    Hum Immunol; 1994 Mar; 39(3):211-9. PubMed ID: 8026989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of two new functional subtypes of HLA-B35.
    Theiler G; Pando M; Delfino JM; Takiguchi M; Satz ML
    Tissue Antigens; 1993 Mar; 41(3):143-7. PubMed ID: 8316945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic heterogeneity of HLA-B35 subtypes in different populations as assessed by DNA typing.
    Satz ML; Fernández-Viña M; Theiler GC; Marcos YC; Lindel N; Capucchio M; Gorodezky C; Fainboim L; Stastny P
    Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):196-203. PubMed ID: 8525479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody.
    Steinle A; Reinhardt C; Nössner E; Uchanska-Ziegler B; Ziegler A; Schendel DJ
    Hum Immunol; 1993 Dec; 38(4):261-9. PubMed ID: 8138421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel HLA-B*35 allele, B*35:188, identified by sequence-based typing.
    Lim AH; Song SN; Shin HH; Kim TE; Kim MH
    Tissue Antigens; 2012 Sep; 80(3):271-2. PubMed ID: 22671860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.
    Morel S; Ooms A; Van Pel A; Wölfel T; Brichard VG; van der Bruggen P; Van den Eynde BJ; Degiovanni G
    Int J Cancer; 1999 Dec; 83(6):755-9. PubMed ID: 10597191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of HLA-B35 alleles and their relationship to HLA-B15 alleles.
    Cereb N; Kim C; Hughes AL; Yang SY
    Tissue Antigens; 1997 Apr; 49(4):389-96. PubMed ID: 9151391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human CTL recognizes a caspase-8-derived peptide on autologous HLA-B*3503 molecules and two unrelated peptides on allogeneic HLA-B*3501 molecules.
    Mandruzzato S; Stroobant V; Demotte N; van der Bruggen P
    J Immunol; 2000 Apr; 164(8):4130-4. PubMed ID: 10754307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two novel alleles at HLA-B locus identified in two volunteer bone marrow donors by sequence-based typing.
    Frison S; Longhi E; Mantovani M; Malagoli A; De Giuli A; Piccolo G; Poli F
    Int J Immunogenet; 2013 Aug; 40(4):328-30. PubMed ID: 23121897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.